Serina Therapeutics, Inc. (SER) Net income 2017–2025
Serina Therapeutics, Inc. (SER) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$19.2MFY2025 · since FY2017: -$6.6M → -$19.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.2M | -72.2% |
| FY2024 | -$11.1M | -311.4% |
| FY2023 | $5.3M | +150.4% |
| FY2022 | -$10.5M | -20.6% |
| FY2021 | -$8.7M | +20.2% |
| FY2020 | -$10.9M | +10.6% |
| FY2019 | -$12.2M | -62.0% |
| FY2018 | -$7.5M | -14.0% |
| FY2017 | -$6.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice